A B S T R A n . A rabbit model of group B Streptococcal (GBS) shock was used to determine if myocardial dysfunction contributes to GBS shock and, if so, to ascertain if prostaglandins modulate this dysfunction. The infusion of heat-killed GBS (group I) ~roduced a dramatic decrease in the first derivative of left ventricular pressure with respect to time (LVdPjdt) from baseline values ( p < 0.05). LVdPj dt remained stable in rabbits pretreated with indomethacin (group 11) and in saline-infused control rabbits (group 111), and was significantly different at 30 min from LVdP/dt in group I ( p < 0.05). Values for group I mean arterial pressure, cardiac output, pulmonary vascular resistance, and heart rate and for pH and p 0 2 after GBS infusion were all significantly different from baseline values and from postinfusion values for groups I1 and I11 (p < 0.05).
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Systemic vascular resistance and left ventricular end diastolic pressure did not change significantly in any group at any time interval. These results indicate a primary role for myocardial dysfunction in the pathogenesis of GBS shock, and suggest strongly that prostaglandins modulate GBSinduced myocardial dysfunction. (Pediatr Res 19:511-513, 1985) Abbreviations GBS, group B Streptococcus PG, prostaglandins PAP, pulmonary artery pressure CO, cardiac output HR, heart rate LVdP/dt, the first derivative of left ventricular pressure with respect to time PVR, pulmonary vascular resistance IND, indomethacin TB2, thromboxane B2 MAP, mean arterial pressure Septic shock due to GBS is a significant cause of mortality in the human fetus and neonate (1, 2). Efforts to identify at-risk pregnancies and to prevent vertical transmission to the fetus are often unsuccessful (1). Conventional treatment of the septic neonate with antibiotics and pressor agents frequently fails to reverse the shock process (1). Improved survival in neonates affected by GBS shock depends on a clearer understanding of the pathogenesis of septic shock, and on the development of new therapeutic modalities aimed at interrupting the shock process.
A variety of animal models for GBS sepsis has been developed for the study of therapeutic strategies and to assess the hemodynamic and hematologic alterations produced by GBS shock. Short et demonstrated an increased survival in the suckling rat model of GBS when animals were treated with prostaglandin synthetase inhibitors. In separate studies in piglets, Runkle et al. (4) and Lunyong and Smith (5) found that infusions of live GBS produced elevated TB2 levels and an increase in PAP. The changes in TB2 and PAP were inhibited by treatment with INTI, further suggesting a role for PG in GBS shock. Rojas et al. (6) have isolated a toxic agent from GBS which in sheep produces elevated PAP, increased pulmonary vascular permeability, granulocytopenia, and increased levels of thromboxane and a pro,stacyclin metabolite (6-Keto-PGFla) in lung lymph. Pretreatment with IND prevented the increased PAP and prevented the rise in TB2 and 6-Keto-PGFla levels in lung lymph. These data from different animal models support previous studies of endotoxin shock suggesting a major pathogenetic role for PG endoperoxides (7).
Although PG are strongly implicated in GBS shock, the possibility that PG may modulate shock through the production of myocardial dysfunction has not been investigated. The purposes of this study were to determine if myocardial dysfunction contributes to GBS shock, and, if so, to ascertain if PG modulate this dysfunction.
MATERIALS AND METHODS
Animal preparation. Adult New Zealand White rabbits received pentobarbital anesthesia and were placed on a sma.11 animal ventilator after tracheostomy. A midline sternotomy was performed, and catheters were inserted into the main pulmona~y artery and left ventricle for measurement of PAP, LVdP/dt, and left ventricular end diastolic pressure. Femoral arterial and venous catheters were placed for measurement of MAP, HEZ, arterial blood gases, and administration of GBS and pharmacologic agents. A 5.0 mm Statham flow probed attached to a Zepacla flow meter was placed on the ascending aorta for measurement of CO. Pulmonani vascular resistance (PVR) was calculated as mean PAP/CO and systemic vascular iesistance was calcu1ate:d as MAP/CO. All hemodynamic variables were recorded on a model R411 Beckman chart recorder. After surgery, animals were stabilized for 30 min. Arterial blood gases were measured every 15 min and ventilation adjusted to maintain an alkalotic, hyperventilated state (pH r 7.6) so that anticipated GBS-induce:d alterations in pH would have minimal impact on MAP, CO, and LVdP/dt.
GBSpreparation. A strain of GBS isolated from the blood of an infant dying with shock was used in all experiments. Before 512 PEEVY ETAL forming units per milliliter and then killed by heating to 100" C for 15 min. Experimental sequence. Animals were assigned randomly to one of three experimental groups. Animals in group I (n = 10) were given heat-killed GBS by constant infusion (0.3 to 0.5 ml/kg/min of 10" GBS/ml) to a total dose of 1012 organisms per kilogram. Values for the measured and derived hemodynamic variables and for arterial blood gases were obtained at baseline and 30 min after the beginning of the infusion. Three animals in group I were given IND (4 mg/kg) after 30-min variables were determined. Animals in group I1 (n = 6) were pretreated with IND (4 mg/kg) 30 rnin before an infusion of heat-killed GBS was given in the same manner as in group I. Hemodynamic and blood gas values were determined at baseline, after IND, and at 30 and 60 rnin after the beginning of the GBS infusion. Control animals (group 111) (n = 6) received a volume of sterile saline equal to the volume of heat-killed GBS used in groups I and I1 and had each variable assessed at the same times.
Statistical analysis was performed on each variable between groups at baseline and 30 rnin using one-way analysis of variance, and within groups at baseline and 30 min using the complete block design analysis of variance with Duncan's test. Survival to 120 min was compared for untreated animals in group I (n = 7), all IND-treated animals in group I (n = 3) and I1 (n = 6), and control animals (n = 6) using X 2 analysis. A p value of <0.05 was considered significant for all comparisons. Table 1 shows the values for LVdP/dt and the other hemodynamic variables at baseline and 30 rnin in control animals (group 111) and in the animals infused with GBS in the presence (group 11) or absence (group I) of IND. The greater than 50% fall in LVdP/dt seen in group I (p < 0.05) was prevented by pretreatment with IND in group 11. The LVdP/dt in group I1 animals were comparable to that in the control group.
RESULTS
The hemodynamic variables obtained from the three study groups are shown in Table 1 . Group I values for MAP, CO, PVR, and HR at 30 rnin were significantly different from the values at 30 min in groups I1 and 111. There were no significant differences within or between groups I1 and 111 at any time interval. Table 2 lists values for pH and p 0 2 at baseline and 30 rnin for each group and at 60 min for groups I1 and 111. The pH and p 0 2 fell significantly in group I by 30 min. A small but statistically significant drop in pH from baseline was noted in group I1 at 60 min but the value was not significantly different from that in group 111.
Survival was monitored for a minimum of 120 min in all groups. The six control animals survived to 120 min. Seven animals in group I received only GBS. Four animals survived to 60 min and two to 120 min. Three animals in group I received IND after the 30-min assessment of variables. All three of those animals and all of the animals pretreated with IND (six of six) in group I1 survived to 120 min. Survival at 120 min was compared using x2 analysis of GBS-infused rabbits with and without IND treatment. IND-treated animals had significantly greater survival (X2 = 6.32, p < 0.05).
DISCUSSION
Our study demonstrates myocardial dysfunction in an adult rabbit model of septic shock induced by GBS. Deterioration of LVdP/dt in response to heat-killed GBS infusion was rapid and was associated with significant declines in MAP, CO, HR, pH, and p02, and a rise in PVR. The hemodynamic changes produced by GBS (group I) were prevented by the prostaglandin synthetase inhibitor IND (group 11). This suggests that alteration of myocardial function in GBS shock is PG dependent.
The magnitude of LVdP/dt is affected by HR, SVR, preload, and the intrinsic contractile state of the heart (8, 9). The 20% fall in HR induced by GBS in group I could be partly responsible for the observed decline in LVdP/dt. However, the relatively 
